Table 1.
Treatments | Glucose uptake (pmol per104 cells per min) | Palmitic acid uptake (pmol per104 cells per min) |
---|---|---|
Control (n=18) | 0.37±0.07 | 7.31±0.22 |
Angiotensin II (n=8) | 0.28±0.09 | 11.41±0.46** |
Angiotensin II+IRB (n=5) | 0.33±0.130 | 5.88±0.62 |
Angiotensin II+PD98059 (n=6) | 0.38±0.10 | 6.52±0.32 |
Angiotensin II+PD123319 (n=5) | 0.22±0.08 | 8.94±0.64* |
Abbreviation: IRB, irbesartan.
**P<0.01, *P<0.05 vs cells not exposed.
The basal glucose and palmitic acid uptake rate was measured in HL-1 cells not exposed and exposed to angiotensin II as described in Methods.